Trials / Completed
CompletedNCT04746105
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
A Study to Evaluate the Respiratory Safety of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate the respiratory safety of TS-142 in patients with mild obstructive sleep apnea hypopnea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-142 | Subjects received single-dose of 10 mg of TS-142 (oral tablet) |
| DRUG | Dose-matched Placebo to TS-142 | Subjects received single-dose matched placebo to TS-142 (oral tablet) |
Timeline
- Start date
- 2021-02-24
- Primary completion
- 2021-10-30
- Completion
- 2021-10-30
- First posted
- 2021-02-09
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04746105. Inclusion in this directory is not an endorsement.